<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00440596</url>
  </required_header>
  <id_info>
    <org_study_id>R21AT002698-01A2</org_study_id>
    <nct_id>NCT00440596</nct_id>
  </id_info>
  <brief_title>Mindfulness Based Stress Reduction for High Blood Pressure</brief_title>
  <official_title>Mindfulness Based Stress Reduction for High Blood Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kent State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Kent State University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly 60 million adults in the United States have high blood pressure (BP) in the&#xD;
      pre-hypertension (SBP 120-139 or DBP 80-89). Hypertension is estimated to account for 1 in 8&#xD;
      deaths in the world, and in the US the direct and indirect costs of high BP are estimated to&#xD;
      reach $59.7 billion in 2005. JNC-7 guidelines recommend lifestyle modifications for&#xD;
      prehypertension, followed by antihypertensive medication if BP progresses to Stage I&#xD;
      hypertension. Mindfulness-based Stress Reduction (MBSR) is an increasingly popular practice&#xD;
      that has been purported to alleviate stress and treat certain health conditions. Some stress&#xD;
      management therapies and one meditation therapy (e.g., Transcendental Meditation) have shown&#xD;
      promise in reducing elevated BP, but MBSR has not been evaluated as a treatment for high BP.&#xD;
      When added to lifestyle modification advice, MBSR may be an appropriate complementary&#xD;
      treatment for prehypertension. However, prior to a large randomized clinical trial of MBSR&#xD;
      for prehypertension and/or hypertension, pilot data is necessary to provide preliminary&#xD;
      evidence of a treatment effect and to evaluate feasibility. This feasibility randomized&#xD;
      clinical trial of MBSR for unmedicated prehypertension will provide preliminary evidence to&#xD;
      support a larger randomized clinical trial by evaluating the feasibility and safety of MBSR&#xD;
      as a complementary treatment for high BP and by documenting any treatment effect. Sixty&#xD;
      patients with unmedicated BP in the range of SBP 120-139 mm Hg or DBP 80-89 mm Hg will be&#xD;
      randomly assigned to MBSR or a progressive muscle relaxation control condition. All patients&#xD;
      will receive lifestyle modification advice. Patients will complete 8 weeks of MBSR delivered&#xD;
      in a group format by an experienced psychologist trained in MBSR or 8 weeks of progressive&#xD;
      muscle relaxation training matched for therapist contact and homework. Patients BP will be&#xD;
      assessed prior to randomization and following treatment by researchers blind to treatment&#xD;
      assignment. Accrual rates, acceptance of randomization, treatment adherence, treatment&#xD;
      fidelity, and patient satisfaction with treatment will be evaluated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SBP</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>DBP</measure>
    <time_frame>12 weeks</time_frame>
    <description>Clinic BP</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Mindfulness based stress reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mindfulness based stress reduction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Progressive Muscle Relaxation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Progressive Muscle Relaxation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness based stress reduction</intervention_name>
    <description>8 weeks group MBSR</description>
    <arm_group_label>Mindfulness based stress reduction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Progressive Muscle Relaxation</intervention_name>
    <description>8 weeks PMR in group format</description>
    <arm_group_label>Progressive Muscle Relaxation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  prehypertension&#xD;
&#xD;
          -  30-60 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  normal BP&#xD;
&#xD;
          -  hypertension&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  use of antihypertensive medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel W Hughes, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kent State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Summa Health System</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 26, 2007</study_first_submitted>
  <study_first_submitted_qc>February 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2007</study_first_posted>
  <results_first_submitted>June 22, 2011</results_first_submitted>
  <results_first_submitted_qc>November 5, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 9, 2020</results_first_posted>
  <last_update_submitted>November 5, 2020</last_update_submitted>
  <last_update_submitted_qc>November 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kent State University</investigator_affiliation>
    <investigator_full_name>Joel Hughes</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>248 Assessed for eligibility 192 excluded</recruitment_details>
      <pre_assignment_details>181 did not meet inclusion criteria 11 did not consent to participate</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>MBSR</title>
          <description>Mindfulness based stress reduction</description>
        </group>
        <group group_id="P2">
          <title>Progressive Muscle Relaxation</title>
          <description>Progressive Muscle Relaxation 8 weeks group treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>MBSR</title>
          <description>Mindfulness based stress reduction</description>
        </group>
        <group group_id="B2">
          <title>Progressive Muscle Relaxation</title>
          <description>Progressive Muscle Relaxation 8 weeks group treatment</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="56"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51.2" spread="5.8"/>
                    <measurement group_id="B2" value="49.5" spread="7.2"/>
                    <measurement group_id="B3" value="50.3" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>SBP</title>
        <time_frame>12 weeks</time_frame>
        <population>56 participatns intent to treat</population>
        <group_list>
          <group group_id="O1">
            <title>MBSR</title>
          </group>
          <group group_id="O2">
            <title>Progressive Muscle Relaxation</title>
          </group>
        </group_list>
        <measure>
          <title>SBP</title>
          <population>56 participatns intent to treat</population>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="130.2" spread="6.3"/>
                    <measurement group_id="O2" value="128.8" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>DBP</title>
        <description>Clinic BP</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MBSR</title>
            <description>Mindfulness based stress reduction</description>
          </group>
          <group group_id="O2">
            <title>Progressive Muscle Relaxation</title>
            <description>Progressive Muscle Relaxation 8 weeks group treatment</description>
          </group>
        </group_list>
        <measure>
          <title>DBP</title>
          <description>Clinic BP</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.3" spread="4.8"/>
                    <measurement group_id="O2" value="78.3" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>MBSR</title>
          <description>Mindfulness based stress reduction</description>
        </group>
        <group group_id="E2">
          <title>Progressive Muscle Relaxation</title>
          <description>Progressive Muscle Relaxation 8 weeks group treatment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joel Hughes</name_or_title>
      <organization>Kent State University</organization>
      <phone>330-672-7721</phone>
      <email>jhughes1@kent.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

